IGFBP7 and type 2 diabetes mellitus: To assess if manipulation of endogenous IGFBP7 affects β-cell physiology, we knocked down IGFBP7 using siRNA in both EndoC-βH1 cells and in islets from three human donors with type 2 diabetes/IGT.